FDA campaign H-0787-2026
Class IIHazard
May be under-processed resulting in growth of Clostridium botulinum and lists health claims.
Distribution
NY and online sales
REKALLD area-alert coverage: nationwide (our reading of the distribution above)
The text above is quoted verbatim from the FDA record. Confirm the affected units and the remedy with the manufacturer or FDA. Recall data may be incomplete, delayed, or superseded.